REHOVOT, ISRAEL/DAVIS, US: Evogene Ltd, a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, and Marrone Bio Innovations Inc, a leading global provider of bio-based pest management and plant health products, announced the signing of a multiyear collaborative agreement targeting the joint discovery of novel modes of biological action for insect control, followed by the development and commercialization of new insect control products by each of the companies.
The partnership will leverage the expertise and distinct assets and capabilities of each company in its respective field, namely Marrone Bio’s expertise in microbial-based solutions for pest control and plant health, and Evogene’s computational gene discovery capabilities. Integrating these industry leading discovery capabilities, the companies will utilize the collaboration’s joint assets to separately develop and commercialize products. Specifically, Evogene will develop biotechnology insect resistance seeds, while Marrone Bio will develop biologically-based insecticides. The parties have agreed on revenue sharing from all insect control products developed through the collaboration.
“This very unique collaboration brings together industry leading and synergistic discovery capabilities to address a major unmet need in agriculture biotechnology. We expect our joint efforts will result in significant product opportunities for both Evogene and Marrone Bio, and we are very pleased to join forces with a company that is an industry leader in its areas of interest. This collaboration demonstrates how Evogene’s established capabilities can be leveraged into new fields and new product types, such as ag-biologicals, while in parallel, broadening the product portfolio in our existing fields by adding two new product programme to our recently launched activity in insect resistance seed traits,” said Ofer Haviv, President and CEO, Evogene states.
© Worldofchemicals News